ArticleAcute and critical care2024

Corrigendum to: Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India: a retrospective cohort study.

Abhyuday Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.